PNS14 BIOSIMILARS: GROWTH AND OPPORTUNITIES

Antibody biosimilars: Fears or opportunities?

The industrial workshop “Antibody biosimilars” was opened by Hervé Watier (CNRS UMR 7292, Université FrançoisRabelais de Tours, France), coordinator of the MAbImprove Laboratory of Excellence. He delivered his welcome address, starting with a quick recall of the LabEx MAbImprove story. This LabEx was created in 2011 and funded by “Investment for the Future” program (French “Big Loan”). He then ...

Biosimilars

Growth Opportunities and Technology Shocks∗

The market value of a firm can be decomposed into two fundamental parts: the value of assets in place and the value of future growth opportunities. We propose a theoreticallymotivated procedure for measuring heterogeneity in growth opportunities across firms. We identify firms with high growth opportunities based on the covariance of their stock returns with the investment-specific productivity...

Islam; Challenges and Opportunities

Undoubtedly Islamic Revolution of Iran has been the source of Islamic awakening in the middle-east. Therefore Islamic Republic of Iran plays the role of an example and a director of political developments in the region. Islamic awakening in Arab countries has been able to question the dominant discourse of dictators in the middle-east region and topple their regimes. These developments include ...

Pituitary Disorders The Role of Recombinant Human Growth Hormone Biosimilars in the Management of Growth Disorders

Since ancient times plant and animal tissues have been used as medicines. In the 20th century growth hormone as a purified extraction from human pituitaries was still used to treat growth disorders. Since the genetic engineering of host cells became possible, a new generation of medicines obtained using recombinant DNA (rDNA) technology has emerged. These medicines have been named ‘biopharmaceu...